Zoek medewerkers/organisaties dr. YPY Vermeiren
Naamdr. YPY Vermeiren

OmschrijvingUniversitair Docent Voeding, Neurochemie en Dementie
OrganisatieDepartement Agrotechnologie en Voedingswetenschappen
OrganisatieeenheidHumane Voeding & Gezondheid
Telefoon+31 317 487 436+31 6 18520620
Mobiel+31 6 18520620+31 6 18520620
Telefoon secretariaat
Telefoon 2
Notitie voor telefonist
Notitie door telefonist
BezoekadresStippeneng 4
Stippeneng 4
Reguliere werkdagen
Ma Di Wo Do Vr
  • Penningmeester/Treasurer, as part of the Executive Board - Trisomy 21 Research Society (T21RS)
    mei 2021 - apr 2027

    Vanaf 1 mei 2021 ben ik aangesteld als onbezoldig penningmeester van de Trisomie 21 Onderzoeksvereniging (afgekort T21RS; www.t21rs.org), en actief deel van de negen leden van de Raad van Bestuur. De T21RS heeft haar zetel in Groningen, Nederland, en is een wetenschappelijke organisatie zonder winstoogmerk (Algemeen Nut Beogende Instelling; ANBI; KvK n°60501162), met als hoofddoel het stimuleren van onderzoek naar Down syndroom, in de ruimste zin van het woord, naast ook het bevorderen van interactie tussen wetenschappers en patiënten- en familieorganisaties, alsook het bevorderen van opleiding en scholing van jonge onderzoekers en het organiseren van een tweejaarlijks congres. ||From 1 May 2021 onwards I am appointed as an unsalaried treasurer of the Trisomy 21 Research Society (abbreviated T21RS; www.t21rs.org), and thus active as one of the nine Executive Board members. The society has its statutory seat in Groningen in the Netherlands, and is a public benefic organization (ANBI; npo; Chamber of Commerce n°60501162). Its main goal is to stimulate Down syndrome’s research, provide educational means for young researchers, stimulate interaction between patient and family organizations and scientists, and, organize a biannual international conference. |||


After successful completion of my Master's in Neurosciences at the University of Antwerp (Belgium), I subsequently focused for my doctoral thesis on the neurochemical characterization of behavioral disturbances in Alzheimer's disease, for which I received the Santkin prize for Alzheimer research in 2016 (Royal Academy of Medicine, Belgium). In addition to my postdoctoral research position at the UAntwerp between 2015-2020, I also got a guest researcher appointment at the Dept. of Neurology of the UMCG and Alzheimer Center Groningen (Netherlands), and actively became involved in various neurochemical, neuropathological and imaging research projects concerning Parkinson's, Lewy body dementia, amyotrophic lateral sclerosis and frontotemporal dementia. From 2017, after acquiring several grants (SAO; Alzheimer Nederland; FWO; JPND) and a senior FWO-VITO fellowship, my research line became centered around noradrenergic alterations in Parkinson's and Down syndrome subjects with(out) Alzheimer's, with special interest into a tiny blueish brainstem nucleus, i.e. the locus coeruleus. My overall research experience thus lies in the domain of behavioral and clinical neurosciences, and neurochemical biomarker studies in neurodegenerative disease, next to studying catecholaminergic and indolaminergic neurotransmitter alterations of noradrenalin, dopamine, and serotonin.

Starting from December 2020 onwards as a fulltime Tenure Track Assistant Professor at the Wageningen University, Division of Human Nutrition & Health, Chair Group of Nutritional Biology, I will combine these previously acquired research skills with the study of nutritional alterations in elderly at risk of neurodegenerative disease. As such, my research focus has now broadened to include preventative measures against Alzheimer's and Parkinson's, primarily looking at diet and lifestyle, or, the microbiota-gut-brain axis. All in all, it should form an innovative blend of combined state-of-the-art clinical, neuroscientific, epidemiological, behavioral, and bioanalytical research, with a great deal of attention to unveiling causal relationships.

Apart from my position at WUR, I also am still affiliated at the UAntwerp (Faculty of Medicine), where I am involved in biomarker dementia studies. Finally, I also recently became selected as Treasurer and member of the Executive Board of the Trisomy 21 Research Society (both unsalaried positions).

On the whole, my ultimate goal in the context of this tenure track trajectory will be to pinpoint neurochemical mechanistic drivers that are inseparable from particular - but most likely modifiable - dietary habits, shortcomings or deficiencies, both in age-related cognitive decline, mild cognitive impairment and forthcoming neurodegenerative diseases, in order to:
(i) unveil novel etiological mechanisms of disease;
(ii) link accompanied behavioral and nutritional disturbances;
(iii) provide corrective, potentially-preventive or relieving, and, disease-specific nutritional care.

The role of tryptophan, the inflammatory kynurenine pathway and serotonin across the microbiota-gut-brain axis in elderly at risk of cognitive deterioration and depression will be one of the topics under investigation (SmartAge-ITN; 2020-2024), next to the effect of a 2-year personalized multidomain lifestyle intervention to maintain optimal cognitive function in aging (MOCIA; 2020-2027).

Sociale media
  Yannick Vermeiren op Twitter
  Yannick Vermeiren op Linkedin

Onderzoeker ID's


HNH-31706 Nutrition and the Brain: Coordinator, Lecturer and Tutor (GWA)

HNH-34106 Nutrition and the Ageing Body: Lecturer

HNH-51806 Interventions for Healthy Ageing in Humans and Model Species (BSc minor course): Coordinator and Lecturer

Caption Text
  • mail
  • chat
  • print